Statins and cancer-related mortality - Let's work together

New England Journal of Medicine

Volumn 367, Issue 19, 2012, Pages 1848-1850

  Caporaso, Neil E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CARDIOVASCULAR DISEASE; COLONOSCOPY; DENMARK; DIABETES MELLITUS; EDITORIAL; HUMAN; INTERDISCIPLINARY RESEARCH; MAMMOGRAPHY; MYALGIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHABDOMYOLYSIS; SIDE EFFECT; SMOKING CESSATION; TUMOR VOLUME;

EID: 84868526455     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1210002     Document Type: Editorial

References (7)

1. Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J Med 2012;367:1792-802.
2. Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S. The controversies of statin therapy: weighing the evidence. J Am Coll Cardiol 2012;60:875-81.
3. Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 2011;305:2556-64.
4. Emberson JR, Kearney PM, Blackwell L, et al. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One 2012;7(1):e29849.
5. Preiss D, Sattar N. Statins and the risk of new-onset diabetes: a review of recent evidence. Curr Opin Lipidol 2011;22:460-6.
6. Barber MJ, Mangravite LM, Hyde CL, et al. Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS One 2010;5(3):e9763.
7. Spitz MR, Caporaso NE, Freedman AN. Epidemiology - found in translation. Cancer Discov 2011;1:21-2.